Factors in the transfer of technology / by Gruber, W. H., Marquis, D. G.

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. by Rodgers, G, Esposito, S, Principi, N, Gutierrez-Brito, M, Diez-Domingo, J, Pollard, A, Snape, MD, Martinón-Torres, F, Gruber, W, Patterson, S, Thompson, A, Gurtman, A, Paradiso, P, Scott, D

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial. by Snape, MD, Klinger, C, Daniels, E, John, T, Layton, H, Rollinson, L, Pestridge, S, Dymond, S, Galiza, E, Tansey, S, Scott, D, Baker, SA, Jones, T, Yu, L, Gruber, W, Emini, E, Faust, SN, Finn, A, Heath, P, Pollard, A

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children by Lum, L.C.S., Borja-Tabora, C.F., Breiman, R.F., Vesikari, T., Sablan, B.P., Chay, O.M., Tantracheewathorn, T., Schmitt, H.J., Lau, Y.L., Bowonkiratikachorn, P., Tam, J.S., Lee, B.W., Tan, K.K., Pejcz, J., Cha, S., Gutierrez-Brito, M., Kaltenis, P., Vertruyen, A., Czajka, H., Bojarskas, J., Brooks, W.A., Cheng, S.M., Rappaport, R., Baker, S., Gruber, W.C., Forrest, B.D.